FDA's monitoring of postmarketing study commitments.
| Corporate Author: | United States. Department of Health and Human Services. Office of Inspector General (Author) |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
[Washington, D.C.] :
Department of Health and Human Services, Office of Inspector General,
2006.
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo71089 |
Similar Items
FDA is issuing more postmarketing requirements, but challenges with oversight persist.
Published: (2016)
Published: (2016)
How FDA approves drugs and regulates their safety and effectiveness /
by: Dabrowska, Agata
Published: (2018)
by: Dabrowska, Agata
Published: (2018)
Testing drugs for physical dependence potential and abuse liability /
Published: (1990)
Published: (1990)
Postmarketing studies of prescription drugs.
Published: (1996)
Published: (1996)
Guidance for industry : implementation of Section 126 of the Food and Drug Administration Modernization Act of 1997, elimination of certain labeling requirements.
Published: (1998)
Published: (1998)
New drug approval : FDA's consideration of evidence from certain clinical trials : report to congressional requesters.
Published: (2010)
Published: (2010)
Ensayos voluntarios de tratamientos médicos en clínicas experimentales.
Published: (2002)
Published: (2002)
FDA oversight of clinical investigators.
Published: (2000)
Published: (2000)
Human subject protection : the FDA's role in a system of safeguards.
Published: (2002)
Published: (2002)
Challenges to FDA's ability to monitor and inspect foreign clinical trials /
Published: (2010)
Published: (2010)
La protección del ser humano : el papel de la FDA en un sistema de seguridad.
Published: (2002)
Published: (2002)
Medical devices: FDA has begun building an active postmarket surveillance system : report to congressional requesters.
Published: (2024)
Published: (2024)
FDA administrative enforcement manual /
by: Parker, Florence R.
Published: (2005)
by: Parker, Florence R.
Published: (2005)
FDA : safeguarding America's health.
Published: (1990)
Published: (1990)
Allegations of FDA abuses of authority : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, July 25, November 15, and December 5, 1995.
Published: (1996)
Published: (1996)
The FDA /
by: Lucas, Scott, 1937-
Published: (1978)
by: Lucas, Scott, 1937-
Published: (1978)
Guidance for industry : postmarketing studies and clinical trials, implementation of section 505(o) of the Federal Food, Drug, and Cosmetic Act.
Published: (2009)
Published: (2009)
FDA consumer protection activities--FDA reorganization : hearings, Ninety-first Congress, first and second session ...
Published: (1970)
Published: (1970)
FDA Checkup : Drug Development and Manufacturing Challenges.
Published: (2013)
Published: (2013)
FDA in the twenty-first century : the challenges of regulating drugs and new technologies /
Published: (2015)
Published: (2015)
Drug Safety : Improvement Needed in FDA's Postmarket Decision-Making and Oversight Process.
Published: (2006)
Published: (2006)
The FDA Commission : the delegation of authority to state and local authorities.
Published: (1989)
Published: (1989)
The FDA Commission : the delegation of authority to state and local authorities.
Published: (1986)
Published: (1986)
FDA drug approval : review time has decreased in recent years : report to congressional requesters.
Published: (1995)
Published: (1995)
Guidance for industry : advisory committees : implementing Section 120 of the Food and Drug Administration Modernization Act of 1997.
Published: (1998)
Published: (1998)
Improving Predictability and Transparency in DEA and FDA Regulations.
Published: (2014)
Published: (2014)
S. 1082 -- The FDA Revitalization Act.
Published: (2007)
Published: (2007)
Science at the FDA : the mainstay of public health protection, new technology is FDA's greatest challenge.
Published: (2002)
Published: (2002)
Preparing for FDA pre-approval inspections /
Published: (1999)
Published: (1999)
FDA protetects the public health : ranks high in public trust.
Published: (2002)
Published: (2002)
FDA drug approval : application review times largely reflect FDA goals : report to congressional requesters.
Published: (2020)
Published: (2020)
Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998.
Published: (1998)
Published: (1998)
FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008.
Published: (2008)
Published: (2008)
Drug Listing Act of 1971.
Published: (1971)
Published: (1971)
FDA's growing responsibilities for the year 2001 and beyond.
Published: (2001)
Published: (2001)
FDA's annual financial report.
Published: (2002)
Published: (2002)
Examining patient access to investigational drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017.
Published: (2018)
Published: (2018)
FDA drug bulletin.
Published: (1971)
Published: (1971)
New drug approval process : the global challenge /
Published: (2000)
Published: (2000)
New drug approval process /
Published: (1993)
Published: (1993)